Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

HERS study results now in -- results counter expectations

Aug. 25, 1998

MDL-103294 and related antioxidants described by Hoechst Marion Roussel

Aug. 24, 1998

Potential cardiovascular agents act by increasing HDL cholesterol

Aug. 24, 1998

Potassium channel blockers in early research at Hoechst

Aug. 20, 1998

Preclinical studies suggest that Tanabe's ETA antagonist holds promise for treating heart failure

Aug. 19, 1998

SB-237376, a new antiarrhythmic agent with a dual mechanism of action and enhanced safety

Aug. 18, 1998

Carotid artery intimal thickening prevented by TAS-301

Aug. 18, 1998

Positive inotropic agent YS-49 shows potential in the treatment of septic shock

Aug. 17, 1998

Novel venotropic agent discovered by Innothera

Aug. 17, 1998

PST-2107, an inotropic agent with potential to outshine digoxin

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...